Press Releases Archives - Clinical Imaging Intelligence https://vidalung.ai/category/press-releases/ Accelerating the Approval and Adoption of Lifesaving Therapies to Patients Wed, 09 Sep 2020 20:39:43 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.3 https://i0.wp.com/vidalung.ai/wp-content/uploads/2020/09/favicon-167.png?fit=32%2C32&ssl=1 Press Releases Archives - Clinical Imaging Intelligence https://vidalung.ai/category/press-releases/ 32 32 223540635 VIDA appoints digital health technology leader Karen Drexler to board of directors, underscoring focus on market expansion of AI solutions https://vidalung.ai/vida-appoints-digital-health-technology-leader-karen-drexler-to-board-of-directors-underscoring-focus-on-market-expansion-of-ai-solutions/?utm_source=rss&utm_medium=rss&utm_campaign=vida-appoints-digital-health-technology-leader-karen-drexler-to-board-of-directors-underscoring-focus-on-market-expansion-of-ai-solutions Tue, 11 Aug 2020 14:57:24 +0000 https://vidalung.ai/?p=10117 Growing bench of proven leaders in clinical lung intelligence and health technology bolsters both product and commercial advances Coralville, IA (August 11, 2020) —VIDA Diagnostics, Inc. (“VIDA”), the leader in lung and respiratory intelligence, announced today that it is has appointed Karen Drexler to its board of directors, further expanding the company’s leadership strength in digital

The post VIDA appoints digital health technology leader Karen Drexler to board of directors, underscoring focus on market expansion of AI solutions appeared first on Clinical Imaging Intelligence.

]]> 10117 Respiratory health AI trailblazer VIDA poised for increased scale with newest appointment to leadership team https://vidalung.ai/respiratory-health-ai-trailblazer-vida-poised-for-increased-scale-with-newest-appointment-to-leadership-team/?utm_source=rss&utm_medium=rss&utm_campaign=respiratory-health-ai-trailblazer-vida-poised-for-increased-scale-with-newest-appointment-to-leadership-team Tue, 07 Jul 2020 13:46:55 +0000 https://vidalung.ai/?p=10057 Todd Johnson joins VIDA, bringing expertise in enterprise imaging, clinical software applications to growing bench of experts for AI-powered pulmonary imaging company Coralville, IA (July  7, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, announced today that Todd Johnson has joined the company as chief technology officer. Johnson, a leader

The post Respiratory health AI trailblazer VIDA poised for increased scale with newest appointment to leadership team appeared first on Clinical Imaging Intelligence.

]]> 10057 VIDA COMPLETES SECOND CLOSE OF ROUND C FINANCING https://vidalung.ai/vida-completes-second-close-of-round-c-financing/?utm_source=rss&utm_medium=rss&utm_campaign=vida-completes-second-close-of-round-c-financing Wed, 15 Apr 2020 13:00:00 +0000 https://vidalung.ai/?p=9689 $2M Second Close from Strategic Partners Completes $13M C Round to Advance AI-Powered Respiratory Solutions Coralville, IA (April 15, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, received $2M from OSF Ventures, the corporate investment arm of OSF HealthCare, as a second close of its C round funding. This investment augments

The post VIDA COMPLETES SECOND CLOSE OF ROUND C FINANCING appeared first on Clinical Imaging Intelligence.

]]> 9689 VIDA Commended by Frost & Sullivan for Transforming Respiratory Disease Care Globally with its LungPrint Suite https://vidalung.ai/vida-commended-by-frost-sullivan-for-transforming-respiratory-disease-care-globally-with-its-lungprint-suite/?utm_source=rss&utm_medium=rss&utm_campaign=vida-commended-by-frost-sullivan-for-transforming-respiratory-disease-care-globally-with-its-lungprint-suite Wed, 01 Apr 2020 14:33:35 +0000 https://vidalung.ai/?p=9612 VIDA provides personalized care solutions that can help pulmonologists identify specific disease phenotypes as well as decide on the most appropriate treatments Note: The following press release was issued by Frost and Sullivan on April 1, 2020 and is republished here in full. SANTA CLARA, Calif., April 1, 2020 /CNW/ -- Based on its recent analysis of

The post VIDA Commended by Frost & Sullivan for Transforming Respiratory Disease Care Globally with its LungPrint Suite appeared first on Clinical Imaging Intelligence.

]]> 9612 VIDA ANNOUNCES SERIES C FINANCING TO ACCELERATE ACCESS TO AI-POWERED LUNG IMAGING ANALYSIS https://vidalung.ai/vida-announces-series-c-financing-to-accelerate-access-to-ai-powered-lung-imaging-analysis/?utm_source=rss&utm_medium=rss&utm_campaign=vida-announces-series-c-financing-to-accelerate-access-to-ai-powered-lung-imaging-analysis Thu, 12 Mar 2020 13:59:00 +0000 https://vidalung.ai/?p=9511 Coralville, IA (March 12, 2020) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, today announced an $11M initial close of its Series C financing. The investment was led by First Analysis Corporation with initial equity participation from Blue Heron Capital and UnityPoint Health Ventures.  Existing investors including Next Level Ventures, Chartline Capital

The post VIDA ANNOUNCES SERIES C FINANCING TO ACCELERATE ACCESS TO AI-POWERED LUNG IMAGING ANALYSIS appeared first on Clinical Imaging Intelligence.

]]> 9511 VIDA PARTNERS WITH TERARECON, INC. FOR DISTRIBUTION OF AI-POWERED LUNG ANALYSIS https://vidalung.ai/vida-partners-with-terarecon-inc-for-distribution-of-ai-powered-lung-analysis/?utm_source=rss&utm_medium=rss&utm_campaign=vida-partners-with-terarecon-inc-for-distribution-of-ai-powered-lung-analysis Mon, 14 Oct 2019 17:10:59 +0000 https://vidalung.ai/?p=9129 Coralville, IA (October 14, 2019) — VIDA Diagnostics, Inc. (“VIDA”), the leader in AI-powered lung imaging analysis, announced a distribution agreement with TeraRecon, Inc., a leader in advanced visualization, artificial intelligence, image viewing, and post-processing. With this agreement, VIDA’s LungPrint® analysis will be available through TeraRecon’s AI Interoperability platform, EnvoyAI, expanding the reach of VIDA’s leading

The post VIDA PARTNERS WITH TERARECON, INC. FOR DISTRIBUTION OF AI-POWERED LUNG ANALYSIS appeared first on Clinical Imaging Intelligence.

]]> 9129 VIDA Expands Board, Announcing Erkan Akyuz As Independent Director https://vidalung.ai/vida-expands-board-announcing-erkan-akyuz-as-independent-director/?utm_source=rss&utm_medium=rss&utm_campaign=vida-expands-board-announcing-erkan-akyuz-as-independent-director Fri, 04 Oct 2019 16:20:41 +0000 https://vidalung.ai/?p=9118 CORALVILLE, Iowa, Oct. 4, 2019 /PRNewswire/ -- VIDA Diagnostics, Inc. ("VIDA"), the leader in AI-powered lung imaging analysis, today announced the appointment of Erkan Akyuz as independent director. Mr. Akyuz will join VIDA's Board of Directors to help guide the company's growth initiatives with differentiated healthcare IT leadership and market expertise. Mr. Akyuz is the President and CEO of both Rhapsody

The post VIDA Expands Board, Announcing Erkan Akyuz As Independent Director appeared first on Clinical Imaging Intelligence.

]]> 9118 VIDA Announces Strategic Investment From UnityPoint Health Ventures https://vidalung.ai/vida-announces-strategic-investment-from-unitypoint-health-ventures/?utm_source=rss&utm_medium=rss&utm_campaign=vida-announces-strategic-investment-from-unitypoint-health-ventures Thu, 25 Jul 2019 13:02:17 +0000 https://vidalung.ai/?p=9078 $1M Investment Combined with Support from the State of Iowa Represents a Shared Vision to Transform Health Care through AI-Powered Innovation Coralville, IA (July 25, 2019) — VIDA Diagnostics, Inc. (VIDA) today announced a strategic partnership and investment from UnityPoint Health Ventures, part of the innovation arm of Iowa’s largest integrated health care system, UnityPoint

The post VIDA Announces Strategic Investment From UnityPoint Health Ventures appeared first on Clinical Imaging Intelligence.

]]> 9078 VIDA Joins Nuance AI Marketplace for Diagnostic Imaging To Deliver Lung Analytics Solutions to Radiologists and Care Teams https://vidalung.ai/vida-joins-nuance-ai-marketplace-for-diagnostic-imaging-to-deliver-lung-analytics-solutions-to-radiologists-and-care-teams/?utm_source=rss&utm_medium=rss&utm_campaign=vida-joins-nuance-ai-marketplace-for-diagnostic-imaging-to-deliver-lung-analytics-solutions-to-radiologists-and-care-teams Tue, 25 Jun 2019 16:51:23 +0000 https://vidalung.ai/?p=9032 CORALVILLE, Iowa, June 25, 2019 /PRNewswire/ -- VIDA Diagnostics, Inc. ("VIDA"), the leader in pulmonary imaging analytics, today announced it has joined the Nuance AI Marketplace for Diagnostic Imaging as a technology partner.  With this agreement, VIDA's LungPrint® Discovery analysis will be available through the Nuance AI Marketplace to 70 percent of all radiologists across more than 6,000 connected healthcare

The post VIDA Joins Nuance AI Marketplace for Diagnostic Imaging To Deliver Lung Analytics Solutions to Radiologists and Care Teams appeared first on Clinical Imaging Intelligence.

]]> 9032